UBS Group’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.5K | Sell |
8,639
-15,667
| -64% | -$115K | ﹤0.01% | 6305 |
|
|
2025
Q1 | $188K | Sell |
24,306
-32,778
| -57% | -$253K | ﹤0.01% | 5357 |
|
|
2024
Q4 | $691K | Buy |
57,084
+53,441
| +1,467% | +$647K | ﹤0.01% | 4491 |
|
|
2024
Q3 | $45.7K | Buy |
3,643
+1,520
| +72% | +$19.1K | ﹤0.01% | 5680 |
|
|
2024
Q2 | $25.3K | Buy |
+2,123
| New | +$25.3K | ﹤0.01% | 6001 |
|
|
2024
Q1 | – | Sell |
-333
| Closed | -$8.56K | – | 8326 |
|
|
2023
Q4 | $8.56K | Sell |
333
-6
| -2% | -$154 | ﹤0.01% | 6334 |
|
|
2023
Q3 | $2.45K | Sell |
339
-1,393
| -80% | -$10.1K | ﹤0.01% | 6556 |
|
|
2023
Q2 | $9.15K | Buy |
+1,732
| New | +$9.15K | ﹤0.01% | 6114 |
|
|
2022
Q3 | – | Sell |
-1,024
| Closed | -$14K | – | 9393 |
|
|
2022
Q2 | $14K | Buy |
+1,024
| New | +$14K | ﹤0.01% | 6362 |
|
|
2022
Q1 | – | Sell |
-694
| Closed | -$5K | – | 9331 |
|
|
2021
Q4 | $5K | Buy |
+694
| New | +$5K | ﹤0.01% | 8270 |
|
|
2021
Q3 | – | Sell |
-348
| Closed | -$11K | – | 8524 |
|
|
2021
Q2 | $11K | Sell |
348
-724
| -68% | -$22.9K | ﹤0.01% | 6863 |
|
|
2021
Q1 | $41K | Buy |
1,072
+289
| +37% | +$11.1K | ﹤0.01% | 5733 |
|
|
2020
Q4 | $37K | Buy |
783
+711
| +988% | +$33.6K | ﹤0.01% | 5455 |
|
|
2020
Q3 | $2K | Sell |
72
-21,350
| -100% | -$593K | ﹤0.01% | 6772 |
|
|
2020
Q2 | $944K | Buy |
21,422
+21,277
| +14,674% | +$938K | ﹤0.01% | 2866 |
|
|
2020
Q1 | $4K | Sell |
145
-365
| -72% | -$10.1K | ﹤0.01% | 6464 |
|
|
2019
Q4 | $26K | Buy |
510
+280
| +122% | +$14.3K | ﹤0.01% | 5668 |
|
|
2019
Q3 | $8K | Buy |
230
+215
| +1,433% | +$7.48K | ﹤0.01% | 6307 |
|
|
2019
Q2 | $1K | Sell |
15
-316
| -95% | -$21.1K | ﹤0.01% | 6835 |
|
|
2019
Q1 | $20K | Sell |
331
-981
| -75% | -$59.3K | ﹤0.01% | 5472 |
|
|
2018
Q4 | $78K | Buy |
1,312
+173
| +15% | +$10.3K | ﹤0.01% | 4864 |
|
|
2018
Q3 | $92K | Buy |
1,139
+248
| +28% | +$20K | ﹤0.01% | 4788 |
|
|
2018
Q2 | $78K | Buy |
891
+717
| +412% | +$62.8K | ﹤0.01% | 4745 |
|
|
2018
Q1 | $34K | Sell |
174
-3,126
| -95% | -$611K | ﹤0.01% | 5138 |
|
|
2017
Q4 | $338K | Buy |
3,300
+54
| +2% | +$5.53K | ﹤0.01% | 3708 |
|
|
2017
Q3 | $123K | Sell |
3,246
-243
| -7% | -$9.21K | ﹤0.01% | 4317 |
|
|
2017
Q2 | $122K | Buy |
3,489
+243
| +7% | +$8.5K | ﹤0.01% | 4167 |
|
|
2017
Q1 | $230K | Sell |
3,246
-78
| -2% | -$5.53K | ﹤0.01% | 3748 |
|
|
2016
Q4 | $243K | Buy |
3,324
+180
| +6% | +$13.2K | ﹤0.01% | 3809 |
|
|
2016
Q3 | $428K | Hold |
3,144
| – | – | ﹤0.01% | 3243 |
|
|
2016
Q2 | $538K | Sell |
3,144
-1
| -0% | -$171 | ﹤0.01% | 3094 |
|
|
2016
Q1 | $594K | Sell |
3,145
-38
| -1% | -$7.18K | ﹤0.01% | 3002 |
|
|
2015
Q4 | $1.12M | Buy |
+3,183
| New | +$1.12M | ﹤0.01% | 2619 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6715 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6788 |
|